However, complications such as damage to central veins, pulmonary complications, cardiac complications, device dysfunction, and catheter-related bloodstream infection are expected to limit adoption of bioresorbable vascular scaffold, thereby hindering the market growth.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients